Related by context. Frequent words. (Click for all words.) 66 R sorafenib tablets 64 MKC# 63 Allovectin 7 ® 62 ATryn ® 62 ® bortezomib 61 Entereg R 61 Phase Ib IIa 61 HepeX B 61 inflammatory autoimmune diseases 61 ZFP Therapeutics 61 Certican 61 refractory chronic lymphocytic 60 Shigamabs ® 60 dextofisopam 60 oncolytic virus therapies 60 ATryn R 60 Daclizumab 60 Initiates Phase II 60 Completes Patient Enrollment 60 peripherally acting 59 topical anti infective 59 ThermoDox R 59 UVIDEM 59 liposomal formulation 59 sorafenib tablets 59 Ketotransdel 59 rheumatoid arthritis psoriatic arthritis 59 forodesine 59 Alair System 59 PRIALT 59 TELINTRA 59 RH1 58 interferon gamma 1b 58 THALOMID 58 non personalized allogeneic 58 Shigamabs R 58 OMS#HP 58 PROMUS Element Stent 58 TYZEKA 58 rufinamide 58 cardio renal 58 Panzem R NCD 58 CDP# 58 CDAD Clostridium difficile 58 ALTROPANE 58 Raptiva ® 58 PSMA ADC 58 AzaSite Plus 58 Pazopanib 58 Allovectin 7 R 58 Loramyc R 58 Trofex 57 thetreatment 57 Icatibant 57 Onco TCS 57 Panzem R 57 Receives Orphan Drug Designation 57 RGB # 57 Filgrastim 57 RhuDex ® 57 beam radiotherapy 57 Zoraxel 57 opioid induced bowel dysfunction 57 Atrigel 57 Soliris TM eculizumab 57 Neo Kidney Augment 57 Tekamlo 56 SEPET TM 56 Litx 56 Somaxon ability 56 Prodarsan ® 56 EFAPROXYN 56 ZymoGenetics intends 56 novel antibody therapeutics 56 confirmatory Phase III 56 BioSante licensees 56 GRNVAC1 56 MOZOBIL 56 TRISENOX 56 Argatroban 56 Phase Ib II 56 phase IIb clinical 56 forodesine HCl 56 Syncria 56 GVAX R 56 AMITIZA R 56 Eligard ® 56 Taxotere docetaxel 56 PRT# 56 Toctino R 56 gets USFDA nod 56 IMC #B 56 Fibrillex TM 56 Investigational Device Exemption 56 BrachySil 56 vernakalant oral 56 Currently RegeneRx 56 Aplidin 56 neratinib 56 Orphan Drug status 56 Proxinium TM